MedPath

CARDSUP - SWISS Circulatory Support Registry

Recruiting
Conditions
Cardiogenic Shock
Registration Number
NCT04117230
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.

Detailed Description

This prospective data collection is made up of an all-comers design, including all eligible consecutive patients receiving an Impella (2.5, 5, CP, or RP) or VA-ECMO device via femoral access who gave their consent (or, if not possible, their relative).

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Age > 18 years
  • Medical indication for implantation of a peripheral cannulated VA-ECMO or microaxial flow pump (IMPELLA) or newer LV / LA-Ascending Aorta devices.
  • Signed informed consent by patient or relative or waived consent by EC
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of deceased participants at 1 month after cardiogenic shock30 days

All-cause mortality at 30 days

Secondary Outcome Measures
NameTimeMethod
Statistical and medical analysis of vascular complications (VARC) reported by participants6 months

Vascular complications (VARC)

Statistical and medical analysis of vascular surgery needed by participants6 months

Need for vascular surgery

Analysis of New York Heart Association (NYHA) Classification for participants6 months

The New York Heart Association (NYHA) Classification provides a way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations during physical activity; the limitations/symptoms are in regards to normal breathing and varying degrees in shortness of breath and or angina pain. Class I is defined as no symptoms and no limitation in ordinary physical activity worsening to Class IV defined as severe limitations.

Statistical and medical analysis of major adverse cardiac and cerebrovascular events (MACCE) reported by participants6 months

Major adverse cardiac and cerebrovascular events (MACCE)

Implantation time of MCS-device6 months

Implantation time of MCS-device

Support time under MCS6 months

Support time under MCS

Modified rankin scale6 months

Modified rankin scale measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological Disability. The scale ranges form 0-6 with 0 defined as no Symptoms and 5 being severe Symptoms and 6 defined as death.

Statistical and medical analysis of bleeding complications (minor, major) reported by participants6 months

Bleeding complications (minor, major)

Number of deceased participants at 6 month after cardiogenic shock6 months

Mortality at 6 months

Trial Locations

Locations (5)

Universitätsspital Basel

🇨🇭

Basel, Switzerland

Insel Gruppe AG, Inselspital Bern

🇨🇭

Bern, Switzerland

Luzerner Kantonsspital

🇨🇭

Luzern, Switzerland

Kantonsspital Winterthur

🇨🇭

Winterthur, Switzerland

Stadtspital Treimli

🇨🇭

ZĂĽrich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath